Alteration of frizzled expression in renal cell carcinoma

Nico Janssens1, Luc Andries, Michel Janicot

  • 1Department of Biochemistry, University of Antwerp, Wilrijk, Belgium. njansse9@prdbe.jnj.com

Insights

Altered expression of frizzled receptors (Fzd) is implicated in kidney cancer. Fzd5 and Fzd8 show increased levels in renal carcinomas, suggesting their potential as biomarkers for Wnt signaling pathway activation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Frizzled receptors (Fzds) are key regulators of the Wnt signaling pathway.
  • Aberrant Wnt signaling is frequently observed in various cancers, including renal carcinoma.
  • The specific role of Fzd family members in renal carcinogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the expression levels of specific Frizzled receptors (Fzds) in human renal tumors.
  • To determine the correlation between Fzd expression and Wnt/beta-catenin signaling pathway activation.
  • To explore the potential of Fzd family members as biomarkers in renal cancer.

Main Methods:

  • Real-time quantitative PCR (qPCR) to assess mRNA expression levels of Fzd family members.
  • Western blot analysis to evaluate Fzd protein expression in matched tumor and normal kidney tissues.
  • Analysis of a kidney tumor tissue array to examine Fzd5 protein expression in a broader sample set.

Main Results:

  • Fzd5 mRNA levels were significantly elevated in 8 out of 11 renal carcinoma samples.
  • Fzd8 mRNA levels were increased in 7 out of 11 renal carcinoma samples.
  • Fzd5 protein expression correlated with mRNA levels, and Fzd5 membrane staining was observed in 30% of clear cell carcinomas, correlating with cyclin D1 expression.

Conclusions:

  • Altered expression of Fzd family members, particularly Fzd5, is associated with renal carcinogenesis.
  • These findings suggest alternative mechanisms for Wnt signaling pathway activation in kidney cancer.
  • Fzd family members may serve as potential biomarkers for renal cancer diagnosis and prognosis.